Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers

被引:21
作者
Zhang, SXD
Bentel, JM
Ricciardelli, C
Horsfall, DJ
Haagensen, DE
Marshall, VR
Tilley, WD [1 ]
机构
[1] Flinders Univ S Australia, Flinders Med Ctr, Sch Med, Dept Surg, Bedford Pk, SA 5042, Australia
[2] Methodist Hosp, Dept Surg, Sacramento, CA USA
基金
英国医学研究理事会;
关键词
prostatic neoplasms; immunohistochemistry; apolipoproteins; androgen receptor; prostate specific antigen;
D O I
10.1016/S0022-5347(01)63981-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To determine the cellular distribution and levels of immunohistochemical staining for apolipoprotein D (Apo-D), prostate specific antigen (PSA) and androgen receptor (AR) in early stage prostate cancers. Materials and Methods: Cellular distribution of Apo-D, PSA and AR in 30 stage A/B prostate cancers and in non-malignant glandular tissue contained in the same sections was detected immunohistochemically, and staining was evaluated by computerized video image analysis. Results: Staining for Apo-D (percentage positive cellular area) was significantly increased in tumor cells of early stage prostate cancers compared with non-malignant glandular tissue. PSA and AR were present at high levels in both early stage prostate tumors and non-malignant prostate. Conclusions: Malignant transformation in the prostate is associated with increased cellular levels of Apo-D.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 50 条
[31]   Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy [J].
Ogreid, P ;
Berner, A ;
Dahl, O ;
Rettedal, E ;
Fosså, SD .
EUROPEAN UROLOGY, 1999, 36 (02) :116-122
[32]   Impact of an Early Prostate-Specific Antigen Response on Biochemical Progression during Upfront Androgen Receptor Signal Inhibitor Therapy for Metastatic Hormone-Sensitive Prostate Cancer [J].
Nirazuka, Asumi ;
Nakayama, Akinori ;
Inoue, Minoru ;
Tsujioka, Hiroki ;
Izumi, Keita ;
Setoguchi, Kiyoshi ;
Arai, Gaku ;
Saito, Kazutaka .
UROLOGIA INTERNATIONALIS, 2025,
[33]   Role of Prostate Volume in the Early Detection of Prostate Cancer in a Cohort with Slowly Increasing Prostate Specific Antigen [J].
Kim, Young Min ;
Park, Sungchan ;
Kim, June ;
Park, Seonghun ;
Lee, Ji Ho ;
Ryu, Dong Soo ;
Choi, Seong Hoon ;
Cheon, Sang Hyeon .
YONSEI MEDICAL JOURNAL, 2013, 54 (05) :1202-1206
[34]   Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer [J].
Hong, Seok Young ;
Cho, Dae Sung ;
Kim, Sun Il ;
Ahn, Hyun Soo ;
Kim, Se Joong .
KOREAN JOURNAL OF UROLOGY, 2012, 53 (09) :607-613
[35]   Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Weinstein, M ;
Tomaszewski, JE ;
Schultz, D ;
Rhude, M ;
Rocha, S ;
Wein, A ;
Richie, JP .
JOURNAL OF UROLOGY, 2001, 166 (06) :2185-2188
[36]   A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range [J].
Catalona, William J. ;
Partin, Alan W. ;
Sanda, Martin G. ;
Wei, John T. ;
Klee, George G. ;
Bangma, Chris H. ;
Slawin, Kevin M. ;
Marks, Leonard S. ;
Loeb, Stacy ;
Broyles, Dennis L. ;
Shin, Sanghyuk S. ;
Cruz, Amabelle B. ;
Chan, Daniel W. ;
Sokoll, Lori J. ;
Roberts, William L. ;
van Schaik, Ron H. N. ;
Mizrahi, Isaac A. .
JOURNAL OF UROLOGY, 2011, 185 (05) :1650-1655
[37]   Characteristics of Prostate Cancers Detected at Prostate Specific Antigen Levels Less Than 2.5 ng/ml [J].
Meeks, Joshua J. ;
Loeb, Stacy ;
Helfand, Brian T. ;
Kan, Donghui ;
Smith, Norm D. ;
Catalona, William J. .
JOURNAL OF UROLOGY, 2009, 181 (06) :2515-2518
[38]   Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with Stage D2 prostate carcinoma [J].
Takeda, H ;
Akakura, K ;
Masai, M ;
Akimoto, S ;
Yatani, R ;
Shimazaki, J .
CANCER, 1996, 77 (05) :934-940
[39]   Interpreting results of prostate-specific antigen testing for early detection of prostate cancer [J].
Meigs, JB ;
Barry, MJ ;
Oesterling, JE ;
Jacobsen, SJ .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (09) :505-512
[40]   Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer [J].
Karazanashvili, G ;
Abrahamsson, PA .
JOURNAL OF UROLOGY, 2003, 169 (02) :445-457